Thymus Imaging Detection and Size Is Inversely Associated With Metabolic Syndrome and Frailty in People With HIV.
HIV
aging
frailty
metabolic syndrome
thymus
Journal
Open forum infectious diseases
ISSN: 2328-8957
Titre abrégé: Open Forum Infect Dis
Pays: United States
ID NLM: 101637045
Informations de publication
Date de publication:
Oct 2019
Oct 2019
Historique:
received:
26
08
2019
accepted:
01
10
2019
entrez:
30
10
2019
pubmed:
30
10
2019
medline:
30
10
2019
Statut:
epublish
Résumé
People with HIV (PWH) may experience accentuating aging in relation to immuno-activation. Little is known regarding thymus (THY) involution in this process. We sought to investigate the relationship between THY imaging detection/size and clinically relevant aging outcomes such as metabolic syndrome (MetS), multimorbidity (MM), and frailty in PWH. This was a cross-sectional observational study including 665 HIV patients (81% males; median age, 53 years) attending Modena HIV Metabolic Clinic from 2014 to 2017. They underwent thoracic computed tomography scan as part of the medical assessment for cardiovascular disease, in which THY detection and size were reported using a semiquantitative score. Outcome measures were MetS, MM, and frailty. THY was detected in 27.0% of subjects; 71.1% showed THY size of grade 1-2, and 28.9% exhibited grade ≥3. Covariates that inversely correlated with THY detection were age, male gender, body mass index (BMI), and HIV duration. Covariates that inversely correlated with MetS were age, HIV duration, BMI, and THY grade 1-2. Covariates that inversely correlated with MM were age, HIV duration, and CD4 nadir. Covariates that inversely correlated with frailty were age, HIV duration, CD4 nadir, BMI, and THY detection. THY is inversely associated with MetS and frailty in PWH.
Sections du résumé
BACKGROUND
BACKGROUND
People with HIV (PWH) may experience accentuating aging in relation to immuno-activation. Little is known regarding thymus (THY) involution in this process. We sought to investigate the relationship between THY imaging detection/size and clinically relevant aging outcomes such as metabolic syndrome (MetS), multimorbidity (MM), and frailty in PWH.
METHODS
METHODS
This was a cross-sectional observational study including 665 HIV patients (81% males; median age, 53 years) attending Modena HIV Metabolic Clinic from 2014 to 2017. They underwent thoracic computed tomography scan as part of the medical assessment for cardiovascular disease, in which THY detection and size were reported using a semiquantitative score. Outcome measures were MetS, MM, and frailty.
RESULTS
RESULTS
THY was detected in 27.0% of subjects; 71.1% showed THY size of grade 1-2, and 28.9% exhibited grade ≥3. Covariates that inversely correlated with THY detection were age, male gender, body mass index (BMI), and HIV duration. Covariates that inversely correlated with MetS were age, HIV duration, BMI, and THY grade 1-2. Covariates that inversely correlated with MM were age, HIV duration, and CD4 nadir. Covariates that inversely correlated with frailty were age, HIV duration, CD4 nadir, BMI, and THY detection.
CONCLUSIONS
CONCLUSIONS
THY is inversely associated with MetS and frailty in PWH.
Identifiants
pubmed: 31660382
doi: 10.1093/ofid/ofz435
pii: ofz435
pmc: PMC6809752
doi:
Types de publication
Journal Article
Langues
eng
Pagination
ofz435Informations de copyright
© The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
Références
J Infect Dis. 2013 Jul 15;208(2):249-59
pubmed: 23559466
Aging Cell. 2006 Apr;5(2):167-75
pubmed: 16626395
PLoS One. 2011 Jan 26;6(1):e16459
pubmed: 21298072
Curr Hypertens Rep. 2016 Jun;18(6):46
pubmed: 27131801
Front Immunol. 2016 Dec 27;7:654
pubmed: 28082988
AIDS. 2015 Aug 24;29(13):1633-41
pubmed: 26372273
Clin Infect Dis. 2011 Dec;53(11):1120-6
pubmed: 21998278
Retrovirology. 2010;7 Suppl 1:I1-32, K1, O1-16, P1-192
pubmed: 20459589
Nature. 2017 Feb 8;542(7640):177-185
pubmed: 28179656
Clin Infect Dis. 2014 Dec 15;59(12):1787-97
pubmed: 25182245
PLoS One. 2017 Oct 19;12(10):e0185761
pubmed: 29049344
J Clin Invest. 1998 Jun 1;101(11):2301-8
pubmed: 9616201
J Infect Dis. 2002 Jun 1;185(11):1578-85
pubmed: 12023763
Eur J Clin Invest. 2005 Jun;35(6):380-7
pubmed: 15948899
AIDS. 2002 Aug 16;16(12):1609-16
pubmed: 12172082
HIV Med. 2017 Nov;18(10):764-771
pubmed: 28737297
Clin Infect Dis. 2015 Feb 15;60(4):627-38
pubmed: 25362204
Immunol Rev. 2016 May;271(1):56-71
pubmed: 27088907
Virulence. 2017 Jul 4;8(5):586-598
pubmed: 27715455
J Acquir Immune Defic Syndr. 2005 Aug 1;39(4):395-400
pubmed: 16010159
Virulence. 2017 Jul 4;8(5):577-585
pubmed: 27540686
Blood. 2011 May 12;117(19):5142-51
pubmed: 21436070
J Gerontol A Biol Sci Med Sci. 2001 Mar;56(3):M146-56
pubmed: 11253156
Age (Dordr). 2013 Feb;35(1):251-9
pubmed: 22095260
Clin Infect Dis. 2017 Jan 15;64(2):152-158
pubmed: 27986677
Eur Radiol. 2016 Jan;26(1):15-24
pubmed: 25925358
J Hepatol. 2015 Jul;63(1):237-64
pubmed: 25911335
Circulation. 2005 Oct 25;112(17):2735-52
pubmed: 16157765
AIDS. 2017 Jun 1;31 Suppl 2:S129-S135
pubmed: 28471943
Diabetologia. 1985 Jul;28(7):412-9
pubmed: 3899825
Curr HIV/AIDS Rep. 2016 Dec;13(6):340-348
pubmed: 27549318
Immunol Today. 1996 Jun;17(6):267-72
pubmed: 8962629
Interdiscip Top Gerontol Geriatr. 2017;42:28-46
pubmed: 27875822
Acta Microbiol Immunol Hung. 2016 Jun;63(2):139-58
pubmed: 27352969
J Gerontol A Biol Sci Med Sci. 2014 Jul;69(7):833-42
pubmed: 24158766